Vaccination directed against the human endogenous retrovirus-K (HERV-K) gag protein slows HERV-K gag expressing cell growth in a murine model system

Vaccination Directed against the Human Endogenous Retrovirus-K Envelope Protein Inhibits Tumor Growth in a Murine Model System

(2013) Benjamin Kraus et al.   PLoS One

Human endogenous retrovirus K (HML-2) RNA and protein expression is a marker for human embryonic and induced pluripotent stem cells

(2013) Nina V Fuchs et al.   Retrovirology

HERV-K–specific T cells eliminate diverse HIV-1/2 and SIV primary isolates

(2012) R. Brad Jones et al.   JOURNAL OF CLINICAL INVESTIGATION

Vaccination with Cancer- and HIV Infection-Associated Endogenous Retrotransposable Elements Is Safe and Immunogenic

(2012) J. B. Sacha et al.   JOURNAL OF IMMUNOLOGY

Expression of Human Endogenous Retrovirus Type K (HML-2) Is Activated by the Tat Protein of HIV-1

(2012) M. J. Gonzalez-Hernandez et al.   JOURNAL OF VIROLOGY

HIV infection and HERV expression: a review

(2012) Antoinette C van der Kuyl   Retrovirology

Selective changes of retroelement expression in human prostate cancer

(2011) Wolfgang Goering et al.   CARCINOGENESIS

Strong Human Endogenous Retrovirus-Specific T Cell Responses Are Associated with Control of HIV-1 in Chronic Infection

(2011) D. SenGupta et al.   JOURNAL OF VIROLOGY

Characterization of the human endogenous retrovirus K Gag protein: identification of protease cleavage sites

(2011) Benjamin Kraus et al.   Retrovirology

Immunogenicity of recombinant Modified Vaccinia Ankara following a single or multi-dose vaccine regimen in rhesus monkeys

(2009) Lauren E. Grandpre et al.   VACCINE

The Poxvirus Vectors MVA and NYVAC as Gene Delivery Systems for Vaccination Against Infectious Diseases and Cancer

(2008) Carmen Gomez et al.   CURRENT GENE THERAPY